Stereotaxis announced on April 21, 2025, that it would host the first-ever live demonstration of its GenesisX Robotic System at the Heart Rhythm Symposium (HRS) from April 24-27 in San Diego, CA. This event offers electrophysiology attendees a direct look at the robot’s clinical capabilities and its innovative 'weekend' installation feature.
GenesisX represents the latest advancement in endovascular surgical robotics, designed to significantly enhance accessibility for healthcare providers. Its compact and efficient design integrates magnetic shielding directly into its structure, eliminating the need for room-based shielding and reducing infrastructure requirements.
The system operates on standard power, requires no structural anchoring, and features an 80% smaller system cabinet that fits under an operating room table. GenesisX obtained CE Mark approval in Europe in 2024 and is currently under review for FDA 510(k) clearance in the United States, with this demonstration aiming to build momentum for its commercial launch.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.